Role of leptin, ghrelin, angiotensin II and orexins in 3T3 L1 preadipocyte cells proliferation and oxidative metabolism

Journal of Physiology and Pharmacology

Volumn 58, Issue SUPPL. 1, 2007, Pages 53-64

  Zwirska Korczala, Krystyna ^a,b   Adamczyk Sowa, M ^a   Sowa, P ^a   Pilc, K ^a   Suchanek, R ^a   Pierzchala, K ^a   Namyslowski, G ^a   Misiolek, M ^a   Sodowski, K ^b   Kato, I ^c   Kuwahara, A ^d   Zabielski, R ^e  

^a Department of Physiology ^*  (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c Yanaihara Institute Inc   (Japan)

^d UNIVERSITY OF SHIZUOKA   (Japan)

^e WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Angiotensin II; Antioxidative enzymes; Ghrelin; Leptin; MDA; Orexin A; Orexin B; Preadipocytes; Proliferation

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II; CATALASE; GHRELIN; GLUTATHIONE PEROXIDASE; LEPTIN; MALONALDEHYDE; OREXIN; OREXIN A; OREXIN B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THYMIDINE;

AEROBIC METABOLISM; ANIMAL CELL; CELL PROLIFERATION; CELL STRAIN 3T3; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ANGIOTENSIN II; ANIMALS; CATALASE; CELL PROLIFERATION; CELLS, CULTURED; GHRELIN; GLUTATHIONE PEROXIDASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALONDIALDEHYDE; MICE; NEUROPEPTIDES; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 35648944178     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue - a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002; 17(2): 191-195.
2. Trayhurn P, Beattie J. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proceedings Nutr Soc 2001; 60: 329-339.
3. Warzecha Z, Dembinski A, Ceranowicz P, et al. Influence of leptin administration on the course of acute ischemic pancreatitis. J Physiol Pharmacol 2002; 53(4): 775-790.
4. Watson AM, Poloyac SM, Howard G, Blouin RA. Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse. Drug Metab Dispos 1999; 27(6): 695-700.
5. Erkasap S, Erkasap N, Koken T, et al. Effect of leptin on renal ischemia-reperfusion damage in rats. J Physiol Biochem 2004; 60(2): 79-84.
6. van Harmelen V, Dicker A, Ryden M, et al. Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 2002; 51(7): 2029-2036.
7. Nanzer AM, Khalaf S, Mozid AM, et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 2004; 151(2): 233-240.
8. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-2991.
9. Lely van der AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004; 25: 426-457.
10. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin - a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55(2): 325-336.
11. Ammoun S, Holmqvist T, Shariatmaderi R, et al. Distinct recognition of OX1 and OX2 receptors by orexin peptides. J Pharm Exp Ther 2003; 305: 507-514.
12. Dalal MA, Schuld A, Haack M, et al. Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 2001; 56: 1749-1751.
13. Ouedraogo R, Naslund E, Kirchgessner AL. Glucose regulates the release of orexin-A from the endocrine pancreas. Diabetes 2003, 52: 111-117.
14. Digby JE, Chen J, Tang JY, Lehnert H, Matthews RN, Randeva HS. Orexin receptor expression in human adiposa tissue: effects of orexin A and orexin B. J Endocrinol 2006; 191(1): 129-136.
15. Ehrstrom M, Gustafsson T, Finn A, et al. Inhibitory effect of exogenous orexin A on gastric emptying, plasma leptin, and the distribution of orexin and orexin receptors in the gut and pancreas in man. J Clin Endocrinol Metab 2005; 90: 2370-2377.
16. Janice J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51(6): 1699-1707.
17. Schling P, Loffler G. Effects of angiotensin II on adipose conversion and expression of genes of the renin-angiotensin system in human preadipocytes. Hormon Metab Res 2001; 33(4): 189-195.
18. Giacchetti G, Faloia E, Mariniello B, et al. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hyperten 2002; 15(5): 381-388.
19. Hu Y, Rosen DG, Zhou Y, et al. Role in cell proliferation and response to oxidative stress. J Biol Chem 2005; 280(47): 39485-39492.
20. Bachmeier M, Loffler G. Influence of growth factors on growth and differentiation of 3T3-L1 preadipocytes in serum-free conditions. Eur J Cell Biol 1995; 68: 323-329.
21. Oyanagui Y. Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 1984; 142: 290-296.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
23. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
24. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
25. Schulz LC, Widmaier EP. The effect of leptin on mouse trophoblast cell invasion. Biol Reprod 2004; 71(6): 1963-1967.
26. Kim MS, Yoon CY, Jang PG, et al. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18(9): 2291-2301.
27. Zhang W, Zhao L, Lin TR, et al. Inhibition of adipogenesis by ghrelin. Mol Biol Cell 2004; 15(5): 2484-2491.
28. Maccarinelli G, Sibilia V, Torsello A, et al. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005; 184(1): 249-256.
29. Delhanty PJ, van der Eerden BC, van der Velde M, et al. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J Endocrinol 2006; 188(1): 37-47.
30. Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, Kral JG. Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 1999; 140: 154-158.
31. Li PG, Xu JW, Ikeda K, et al. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28(4): 369-377.
32. Nagata D, Takeda R, Sata M, et al. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation. Circulation 2004; 110(4): 444-451.
33. Kyaw M, Yoshizumi M, Tsuchiya K, et al. Antioxidant effects of stereoisomers of N-acetylcysteine (NAC), L-NAC and D-NAC, on angiotensin II-stimulated MAP kinase activation and vascular smooth muscle cell proliferation. J Pharmacol Sci 2004; 95(4): 483-486.
34. Yang X, Zhu MJ, Sreejayan N, Ren J, Du M. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol Cells 2005; 20(2): 263-270.
35. Spinazzi R, Ziolkowska A, Neri G, et al. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44-and p38-dependent cascades. Int J Molecular Med 2005; 15: 847-852.
36. Ramsay TG. Porcine leptin alters insulin inhibition of lipolysis in porcine adipocytes in vitro. J Anim Sci 2001; 79(3): 653-657.
37. Yamagishi S, Edelstein D, Du X, Kaneda Y, Guzman M, Brownlee M. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001; 276(27): 25096-25100.
38. Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 2002; 190(1-2): 91-99.
39. Iseri SO, Sener G, Yuksel M, et al. Ghrelin against alendronate-induced gastric damage in rats. J Endocrinol 2005; 187(3): 399-406.
40. Rueckschloss U, Quinn MT, Holtz J, Morawietz H. Blockade in patients with coronary artery disease in human endothelial cells: protective effect of angiotensin II type 1 receptor dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II. Arterioscler Thromb Vasc Biol 2002; 22:1845-1851.
41. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406-413.
42. Adler S, Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 2004; 287: F907-F913.
43. Lopez M, Senaris R, Gallego R, et al. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 1999; 140: 5991-5994.
44. Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox ChS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 2005; 288: H22-H28.
45. Chiarelli F, Di Marzio D, Santilli F, et al. Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Diabetes Care 2005; 28(7): 1690-1697.